ArticleFrontiers in cellular and infection microbiology2025

A pharmacovigilance study on probiotic preparations based on the FDA Adverse Event Reporting System from 2005 to 2023.

Yitong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.